Evidence map›Paper›PMID 30040425›Full record

ArticleJournal of natural products2018

A Bioactive Resveratrol Trimer from the Stem Bark of the Sri Lankan Endemic Plant Vateria copallifera.

Saroopa P Samaradivakara, Radhika Samarasekera, Shiroma M Handunnetti, O V D S Jagathpriya Weerasena, Ayad A Al-Hamashi, James T Slama, William R Taylor, Qasim Alhadidi, Zahoor A Shah, Lalith Perera and 1 more

Abstract read
In one paragraph

Article in Journal of natural products, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saroopa P SamaradivakaraInstitute of Biochemistry, Molecular Biology and Biotechnology , University of Colombo , 90, Cumaratunga Munidasa Mawatha , Colombo 03 , Sri Lanka.ORCID 0000-0002-8637-8738
Radhika SamarasekeraIndustrial Technology Institute , 363, Bauddhaloka Mawatha , Colombo 07 , Sri Lanka.
Shiroma M HandunnettiInstitute of Biochemistry, Molecular Biology and Biotechnology , University of Colombo , 90, Cumaratunga Munidasa Mawatha , Colombo 03 , Sri Lanka.
O V D S Jagathpriya WeerasenaInstitute of Biochemistry, Molecular Biology and Biotechnology , University of Colombo , 90, Cumaratunga Munidasa Mawatha , Colombo 03 , Sri Lanka.
Ayad A Al-Hamashi
James T Slama
William R Taylor
Qasim Alhadidi
Zahoor A Shah
Lalith PereraGenome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences , National Institutes of Health, Department of Health and Human Services , Research Triangle Park , Durham , North Carolina 27709-2233 , United States.ORCID 0000-0003-0823-1631
L M Viranga TillekeratneORCID 0000-0002-8326-564X

Funding

Macromolecular ModelingZICES043010 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI COPELAND, WILLIAM · 2012 to 2025
$5.7M
MACROMOLECULAR MODELING AND CARCINOGENESISZ01ES043010 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI DARDEN, THOMAS A · 1986 to 2008
$1.2M
Novel Small Molecule Ferroptotic Compounds to Target Mesenchymal Breast Cancer and Breast Cancer Stem CellsR15CA213185 · NCI · UNIVERSITY OF TOLEDO · PI TILLEKERATNE, VIRANGA · 2018 to 2018
$449k
Chemobiologic Approach to NAADP SignalingR15GM100444 · NIGMS · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SLAMA, JAMES T · 2012 to 2012
$351k
Regulation of Sororin by Cdk1-mediated Phosphorylation.R15GM100440 · NIGMS · UNIVERSITY OF TOLEDO · PI TAYLOR, WILLIAM R. · 2012 to 2012
$291k
Intramural NIH HHS Z01 ES043010NCI NIH HHS R15 CA213185NIGMS NIH HHS R15 GM100440NIGMS NIH HHS R15 GM100444
6 · The paper itself

Abstract

A new resveratrol trimer, vateriferol (1), having four cis-oriented methine protons and constituting four contiguous stereocenters, was isolated from the bark extract of Vateria copallifera by bioassay-guided fractionation using a combination of normal, reversed phase, and size exclusion column chromatography. The structure was established based on its spectroscopic data. Vateriferol (1) was evaluated in vitro for its antioxidant capacity, enzyme inhibitory activity, growth inhibitory activity on a number of cancer cell lines, neuroprotective activity, and anti-inflammatory activity. Vateriferol (1) exhibited AChE inhibitory activity (IC

Indexed as

AnimalsAntineoplastic Agents, PhytogenicAntioxidantsDipterocarpaceaeDrug Screening Assays, AntitumorEnzyme InhibitorsMolecular StructureNeuroprotective AgentsPC12 CellsPlant BarkRatsResveratrolSri LankaAntineoplastic Agents, PhytogenicAntioxidantsEnzyme InhibitorsNeuroprotective AgentsResveratrol

Identifiers

PMID30040425
PMCPMC7015271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.